| 回到 StockQ 正常版首頁 |
百達健康基金-R
| ||||||||||||
| 年度報酬率 |
| 2020 | 2021 | 2022 | 2023 | 2024 |
| 9.32% | 12.08% | -19.89% | 8.12% | 3.31% |
| 百達健康基金-R |
| 此成分基金的目標是至少以其總資產的三分之二,分散投資於從事非專利藥物行業的公司所發行股份,以達致資本增長。此成分基金的投資並沒有地域上的限制。 |
| 日期 | 淨值 | 漲跌比例 |
| 2025/12/04 | 294.3800 | 0.28% |
| 2025/12/03 | 293.5500 | -0.06% |
| 2025/12/02 | 293.7300 | -0.44% |
| 2025/12/01 | 295.0200 | 0.31% |
| 2025/11/28 | 294.1000 | -0.24% |
| 2025/11/26 | 294.8200 | 1.07% |
| 2025/11/25 | 291.7000 | 0.76% |
| 2025/11/24 | 289.4900 | 0.84% |
| 2025/11/21 | 287.0800 | -1.20% |
| 2025/11/20 | 290.5600 | 0.44% |
| 名稱 | 三個月 | 六個月 | 一年 | 今年 |
| 百達健康基金-R/美元 | 1.66% | -1.64% | -7.32% | -3.47% |
| NBI生技指數 | 21.14% | 37.54% | 25.16% | 33.72% |
| 費城藥物指數 | 0.00% | 0.00% | 0.00% | 0.00% |
| AMEX生技指數 | 21.72% | 30.28% | 23.14% | 28.58% |
| MSCI 全球醫療保健指數 (price) | 0.00% | 4.81% | 619.49% | -97.64% |
| MSCI 製藥指數 (price) | 436.41% | -95.67% | -95.89% | -95.70% |
| MSCI 生物科技指數 (price) | 12.79% | 18.14% | 12.06% | 17.31% |
| 聯博國際醫療基金-A股/美元 | 9.89% | 11.44% | 1.09% | 8.96% |
| 安聯全球生物科技基金/歐元 | 19.41% | 32.41% | 9.33% | 15.04% |
| 安聯全球生技趨勢基金/台幣 | 18.42% | 33.12% | 12.26% | 19.01% |
| 貝萊德世界健康科學基金A2/歐元 | 9.60% | 10.40% | -4.31% | -0.36% |
| 貝萊德世界健康科學基金A2/美元 | 9.84% | 12.93% | 5.84% | 12.06% |
| 法巴健康護理創新股票基金-C股/美元 | 15.62% | 21.92% | 10.18% | 18.24% |
| 群益全球關鍵生技基金/台幣 | 14.36% | 23.62% | 3.73% | 9.57% |
| 群益全球關鍵生技基金/美元 | 12.14% | 18.36% | 7.68% | 14.60% |
| 國泰科技生化基金/台幣 | 21.51% | 63.32% | 32.69% | 36.74% |
| 富達永續發展全球健康護理基金/歐元 | 5.03% | 5.08% | -12.72% | -7.83% |
| 富蘭克林坦伯頓生技領航基金-A/累積/美元 | 32.91% | 58.00% | 41.52% | 50.75% |
| 富蘭克林華美生技基金/台幣 | 32.24% | 61.50% | 37.33% | 43.17% |
| 景順健康護理創新基金-A股/美元 | 10.59% | 16.10% | 9.00% | 16.29% |
| 駿利亨德森環球生命科技基金-A2/美元 | 18.48% | 26.04% | 12.02% | 20.67% |
| 駿利亨德森環球生命科技基金-B2/美元 | 18.21% | 25.41% | 10.91% | 19.57% |
| 駿利亨德森環球生命科技基金-A2/歐元避險 | 17.80% | 24.44% | 9.65% | 18.30% |
| 駿利亨德森環球生命科技基金-I2/歐元避險 | 18.05% | 24.94% | 10.56% | 19.20% |
| 駿利亨德森環球生命科技基金-I2/美元 | 18.73% | 26.54% | 12.95% | 21.58% |
| 野村全球生技醫療基金/台幣 | 13.03% | 19.95% | 4.46% | 10.81% |
| 百達生物科技基金-HR/歐元 | 29.92% | 54.01% | 33.81% | 45.10% |
| 百達生物科技基金-R/歐元 | 30.42% | 52.48% | 23.66% | 32.11% |
| 百達生物科技基金-R/美元 | 30.70% | 55.95% | 37.35% | 48.58% |
| 百達健康基金-HR/歐元 | 1.02% | -2.94% | -9.64% | -5.71% |
| 百達健康基金-R/歐元 | 1.44% | -3.83% | -16.56% | -14.16% |
| 瑞銀(盧森堡)生化股票基金/美元 | 22.62% | 40.68% | 30.47% | 38.95% |
| 瑞銀(盧森堡)保健股票基金/美元 | 13.69% | 19.61% | 12.84% | 19.62% |
| 新加坡大華全球保健基金/星幣 | 15.99% | 20.55% | 2.53% | 8.35% |
| 新加坡大華全球保健基金/美元 | 15.47% | 20.03% | 6.63% | 14.25% |
| ||||||||||||
|
StockQ 全球股市指數 © All rights reserved.
|